Russo Partners

In this episode of the Russo Edge Podcast with host solomon wilcots, Graig Suvannavejh, PhD, of Mizuho highlights what’s driving biotech and pharm investments. Graig highlights obesity as a central focus, with companies strategizing around approaches like GLP-1 and beyond. He explains that the future could see novel therapies targeting mechanisms like myostatin inhibition, CB1 receptors, and even the inflammasome. Listen here: https://bit.ly/3BVpE4G Apple Podcasts: https://apple.co/4dVG0Yd Spotify: https://spoti.fi/48uMCvx YouTube: https://bit.ly/40mqC3Z #Biotech #Biopharma #Investors #InvestorPodcast

Don't miss this compelling discussion led by David Schull at #BioFuture2024 on #AI.

In biotech, communications are everything. In his latest article, our CEO, Tony Russo, Ph.D., dives into how early-stage biotech companies can stand out with clear, compelling messages that resonate with key stakeholders. At Russo Partners, we show you how a strategic communications plan can build credibility, attract investment, and keep your company on track for success. Read the full article on LinkedIn: https://bit.ly/48GreUx #CommunicationsStrategy #LifeSciences

🎧 solomon wilcots of Russo Partners chats with Graig Suvannavejh, PhD, of Mizuho for his expert insight into what biotech and biopharma investments will look like at the end of this year. Graig shares his insights on the evolving biotech sector, the impact of high interest rates on smaller companies, and emerging therapeutic areas poised for growth. Don't miss this in-depth discussion on the future of biotech investing. To listen to the episode, visit: https://bit.ly/3BVpE4G Apple Podcasts: https://apple.co/4dVG0Yd YouTube: https://bit.ly/4f8JxDS #Biotech #Biopharma #Investors #InvestorPodcast

The #AI revolution in healthcare is making waves in New York’s #HealthTech market, with venture capital investments already surpassing $1 billion in 2024. From drug discovery to streamlining administrative tasks like insurance claims, AI is helping to solve long-standing challenges. Read more from Modern Healthcare: https://bit.ly/3Aeqnxg #Innovation #HealthcareAI #VC

Thanks so much to former NFL-er, sports announcer, and all-around great guy solomon wilcots and the team at Russo Partners for recently having me as a guest on the Russo Edge podcast for a lively discussion on the biotech sector. We explored the evolving biotech landscape, upcoming events and catalysts, and key therapeutic areas poised for growth, and we also touched on best practices for companies looking to strengthen relationships with research analysts and investors. @Mizuho #ThisIsMizuho

🎧 solomon wilcots of Russo Partners chats with Graig Suvannavejh, PhD, of Mizuho for his expert insight into what biotech and biopharma investments will look like at the end of this year. Graig shares his insights on the evolving biotech sector, the impact of high interest rates on smaller companies, and emerging therapeutic areas poised for growth. Don't miss this in-depth discussion on the future of biotech investing. To listen to the episode, visit: https://bit.ly/3BVpE4G Apple Podcasts: https://apple.co/4dVG0Yd YouTube: https://bit.ly/4f8JxDS #Biotech #Biopharma #Investors #InvestorPodcast

Unforgettable teamwork on an anniversary: The Russo Partners Sports-Health Alliance led by solomon wilcots, our video production team, together with Ohio Federal Research Network (OFRN) (previously BioOhio), Cleveland Browns Hall of Famer Joe Thomas, led to this documentary “Disruptors in Believeland,” spotlighting Cleveland as a biomedical hub. Released 6 years ago, it is still compelling! https://bit.ly/3UavDZJ Can sports personalities and video storytelling elevate your messaging? Contact us! #VideoProduction #SportsHealth

🎙️On the Russo Edge podcast, host solomon wilcots of Russo Partners chats with Brian Culley, CEO of Lineage Cell Therapeutics, about the potential of cell therapy to address spinal cord injuries, a leading cause of mobility loss. To listen to the episode, visit: https://bit.ly/4ePZ5N0 Apple Podcasts: https://apple.co/4eMNbn0 YouTube: https://bit.ly/3YbthuJ #SCI #HealthcareInnovation

Sparks were flying at our official launch of Hezkue® at the Congress of German Society for Urology. We are proud to bring our unique oral spray formulation to new markets and are energized by the enthusiasm we received at our launch event. Thank you to IPG Health and Inizio for all your support during this exciting time.   Hezkue® is an oral liquid suspension of sildenafil citrate administered via a spray pump that delivers the precise amount per push based on patient need.   #Urology #HealthcareInnovation #Sildenafil